Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/IIA Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects

NCT01144026 is registered in ClinicalTrials.gov with Thymon, LLC as lead sponsor.

NCT NCT01144026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01144026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/IIA Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects
Lead sponsor
Thymon, LLC
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2010
Completion date
April 30, 2011
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections